Clinical Trials

40 enrolled

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT03384914 2026-03-06

Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer

119 enrolled

Breast Neoplasms, Neoplasm, Residual, Breast Neoplasms, Male

NCT06719700 2026-03-03

Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer

47 enrolled

Small Cell Lung Carcinoma

NCT02645149 2026-02-27

Match Mel

216 enrolled

Dermatologic

Melanoma

NCT04594187 2026-02-17

MelPORT

168 enrolled

Dermatologic

Melanoma

NCT06943235 2026-02-11

Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)

60 enrolled

Limited Stage Small Cell Lung Cancer

NCT07397442 2026-02-11

Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

19 enrolled

Pathologic Complete Response, Rectal Neoplasms

NCT06610734 2026-02-09

SKY

202 enrolled

Small Cell Lung Cancer Extensive Stage

NCT06810609 2026-01-27

InDuRanS

176 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05978193 2026-01-22

SCR-ESCC-01

100 enrolled

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT07259473 2026-01-07

Pre-CATALIS

15 enrolled

Turcot syndrome

NCT07293247 2025-12-22

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

164 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07297030 2025-12-22

SIB-RT Combined With CAPOX and PD-1 for High-Risk Rectal Cancer

37 enrolled

Phase 2 Active not recruiting

Rectal Neoplasms

NCT03614949 2025-12-19

SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

21 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06102057 2025-12-17

PACCELIO

110 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07258147 2025-12-02

Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases

30 enrolled

Lung Neoplasms

NCT07254858 2025-11-28

CISN-L

302 enrolled

Breast Neoplasms

NCT07250542 2025-11-26

A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer

30 enrolled

Genitourinary

Prostatic Neoplasms

NCT04454489 2025-11-19

Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition

21 enrolled 18 charts

Squamous Cell Carcinoma of Head and Neck

NCT06804850 2025-11-19

Neoadjuvant Radiotherapy Plus Targeted Therapy and Immunotherapy vs. Targeted Therapy Plus Immunotherapy in Resectable HNSCC

Phase 2 Withdrawn

Head and Neck Neoplasms

NCT07231575 2025-11-18

Neoadjuvant SBRT and Tislelizumab (Immunotherapy) Plus Anlotinib for Resectable EGFR Wild-type NSCLC

39 enrolled

Neoadjuvant Immunotherapy

NCT07154082 2025-09-04

Apatinib Mesylate and Camrelizumab Combined With TACE as Neoadjuvant Therapy for Hepatocellular Carcinoma

27 enrolled

Carcinoma, Hepatocellular

NCT07130240 2025-08-19

Ivonescimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy Followed by Type A Hysterectomy in Stage IB2 and IIA1 Cervical Cancer

20 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT07118566 2025-08-12

Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases

40 enrolled

Hyperthermia, Gastrointestinal Neoplasms

NCT03623646 2025-08-08

CITHARE

11 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT07014202 2025-07-30

Consolidation Radiotherapy vs. Observation in Oligoresidual Advanced Non-Small Cell Lung Cancer After Chemo-Immunotherapy

224 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06811844 2025-07-01

Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC

208 enrolled

Pathologic Complete Response, Nasopharyngeal Neoplasms

NCT06356584 2025-06-26

Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases

62 enrolled

Colorectal Neoplasms

NCT07015489 2025-06-11

Concurrent Radiotherapy Following Induction Chemoimmunotherapy for Locally Advanced Esophageal Cancer

44 enrolled

ESCC

NCT06908668 2025-04-03

Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer

170 enrolled

HER2-Negative Locally Advanced Breast Cancer

NCT06878222 2025-04-01

Iparomlimab and Tuvonralimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy for CC

35 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06849167 2025-02-27

Immunotherapy Combined with Hypofractionated Concurrent Chemoradiotherapy Followed by Immunotherapy in LA-NSCLC

63 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06691594 2025-02-20

Neoadjuvant Treatment of Triple-Negative Breast Cancer with Stereotactic Radiotherapy, PD-1 Monoclonal Antibody, and Chemotherapy

20 enrolled

Triple Negative Breast Neoplasms

NCT04724928 2025-01-15

EFFORT-MIBC

156 enrolled

Muscle-Invasive Bladder Carcinoma

NCT06718309 2024-12-05

Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC

40 enrolled

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT06700421 2024-11-22

Phase II Clinical Study of Adebrelimab Combined with Apatinib in the Treatment of Locally Advanced Non-small Cell Lung Cancer Patients with Radiation Pneumonitis

32 enrolled

Radiation Pneumonitis

NCT05462496 2024-10-15

Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer

25 enrolled

Pancreatic Neoplasms

NCT06199882 2024-10-15

SBRT Sequential Surufatinib Combined With Immunotherapy for Biliary Tract Carcinoma

Phase 2 Suspended

34 enrolled

Biliary Tract Carcinoma

NCT06599827 2024-09-19

iMHRT-LARC

54 enrolled

Rectal Neoplasms

NCT02949843 2024-06-28

Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations

Phase 2 Terminated

19 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung

NCT06359275 2024-06-25

PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients

81 enrolled

Pancreatic Neoplasms

NCT06084897 2024-06-14

Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus Chemotherapy

120 enrolled

Esophageal Neoplasms

NCT05584267 2024-05-30

Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy

140 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06341530 2024-04-02

Anlotinib Combined With Penpulimab as Front-line Treatment in Advanced Non-small Cell Lung Cancer

33 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06032052 2024-03-15

Single-drug Chemotherapy Plus Immunotherapy in Metastatic Non-small Cell Lung Cancer Elderly Patients

49 enrolled

Lung Neoplasms

NCT06249750 2024-02-08

Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer

60 enrolled

Hyperthermia

NCT05237349 2024-01-05

Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma

Phase 2 Unknown

38 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT06170697 2023-12-20

Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma

Phase 2 Unknown

46 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT06009029 2023-08-24

SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study)

96 enrolled